Cytokines in New‐Onset Refractory Status Epilepticus Predict Outcomes - Sorbonne Université Access content directly
Journal Articles Annals of Neurology Year : 2023

Cytokines in New‐Onset Refractory Status Epilepticus Predict Outcomes


Objective: The objective of this study was to investigate inflammation using cerebrospinal fluid (CSF) and serum cytokines/chemokines in patients with new-onset refractory status epilepticus (NORSE) to better understand the pathophysiology of NORSE and its consequences. Methods: Patients with NORSE (n = 61, including n = 51 cryptogenic), including its subtype with prior fever known as febrile infection-related epilepsy syndrome (FIRES), were compared with patients with other refractory status epilepticus (RSE; n = 37), and control patients without SE (n = 52). We measured 12 cytokines/chemokines in serum or CSF samples using multiplexed fluorescent bead-based immunoassay detection. Cytokine levels were compared between patients with and without SE, and between the 51 patients with cryptogenic NORSE (cNORSE) and the 47 patients with a known-etiology RSE (NORSE n = 10, other RSE n = 37), and correlated with outcomes. Results: A significant increase of IL-6, TNF-α, CXCL8/IL-8, CCL2, MIP-1α, and IL-12p70 pro-inflammatory cytokines/chemokines was observed in patients with SE compared with patients without SE, in serum and CSF. Serum innate immunity pro-inflammatory cytokines/chemokines (CXCL8, CCL2, and MIP-1α) were significantly higher in patients with cNORSE compared to non-cryptogenic RSE. Patients with NORSE with elevated innate immunity serum and CSF cytokine/chemokine levels had worse outcomes at discharge and at several months after the SE ended. Interpretation: We identified significant differences in innate immunity serum and CSF cytokine/chemokine profiles between patients with cNORSE and non-cryptogenic RSE. The elevation of innate immunity pro-inflammatory cytokines in patients with NORSE correlated with worse short- and long-term outcomes. These findings highlight the involvement of innate immunity-related inflammation, including peripherally, and possibly of neutrophil-related immunity in cNORSE pathogenesis and suggest the importance of utilizing specific anti-inflammatory interventions.
Fichier principal
Vignette du fichier
HaninCytokinesManuscript.pdf (1.74 Mo) Télécharger le fichier
Origin Files produced by the author(s)

Dates and versions

hal-04037546 , version 1 (20-03-2023)



Aurélie Hanin, Jorge Cespedes, Karim Dorgham, Yashwanth Pulluru, Margaret Gopaul, et al.. Cytokines in New‐Onset Refractory Status Epilepticus Predict Outcomes. Annals of Neurology, 2023, ⟨10.1002/ana.26627⟩. ⟨hal-04037546⟩
356 View
378 Download



Gmail Mastodon Facebook X LinkedIn More